Effectiveness of gene delivery systems for pluripotent and differentiated cells
Human embryonic stem cells (hESC) and induced pluripotent stem cells (hiPSC) assert a great future for the cardiovascular diseases, both to study them and to explore therapies. However, a comprehensive assessment of the viral vectors used to modify these cells is lacking. In this study, we aimed to...
Main Authors: | Kleopatra Rapti, Francesca Stillitano, Ioannis Karakikes, Mathieu Nonnenmacher, Thomas Weber, Jean-Sebastian Hulot, Roger J Hajjar |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050116300110 |
Similar Items
-
Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells
by: Francesca Stillitano, et al.
Published: (2017-01-01) -
Concise Review: Precision Matchmaking: Induced Pluripotent Stem Cells Meet Cardio‐Oncology
by: Pooja Nair, et al.
Published: (2019-08-01) -
Bacterial delivery of nuclear proteins into pluripotent and differentiated cells.
by: Candace Bichsel, et al.
Published: (2011-01-01) -
Immunogenicity of pluripotent stem cells and their differentiation products
by: Monecke, Sebastian
Published: (2013) -
Association of the invariant chain (CD74) and human leucocyte antigen (HLA) DR : a single molecule approach
by: Karakikes, Ioannis
Published: (2003)